Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New counseling approach aims to curb youth suicide risk

NCT ID NCT07321171

Symptom relief Sponsor: Shira Barzilay Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a stepped-care model where youth with mild suicidal thoughts get brief counseling from trained non-specialists, while those with more severe risk receive professional therapy. Researchers will compare this approach to standard care in 350 children and teens. The goal is to see if the model reduces suicidal thoughts and behaviors and improves access to treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
brief interpersonal counseling (IPC) delivered by trained non-specialists
What this could lead to
If successful, this could provide a cost-effective, scalable way to reduce suicidal thoughts and behaviors in children and teens.
What could go wrong
This is an early-stage trial with 350 participants, so results may not apply to all youth. The intervention is low-intensity and may not work for severe cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must be between 6 and 18 years old, inclusive. * Participants currently exhibit various forms of STB, including suicidal thoughts, gestures, behaviors, or attempted suicide. Exclusion Criteria: * Acute medical conditions. * Current psychotic disorders. * Non-fluency in Hebrew (language of intervention and assessment). * Diagnosed intellectual disability. * Diagnosed neurodevelopmental disorders (other than those that commonly co-occur with STB and are deemed manageable by the study team). * Inability to provide informed consent (participant) or parental permission (parent/guardian).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal ideation and behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior Suicidal Ideation Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicidal ideation and behavior

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shneider children's Medical Center

    RECRUITING

    Petah Tikva, 4920235, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.